Abstract
We have previously shown that ex vivo insertion of a gene encoding the mycobacterial heat shock protein-65 into tumour cells results in their inability to form tumours in mice. We report regression of highly malignant reticulum cell sarcomas (J774) after liposome-mediated gene transfer in vivo. Heat shock gene transfer resulted in tumour regression both in immunocompetent and immunodeficient SCID mice. Complete tumour eradication, however, was detected only in immunocompetent animals, confirming the role of T cells in tumour rejection. Treatment of tumour bearing mice with the heat shock gene–liposome complex resulted in the production of antibodies against the tumour cells, indicating an increase in the antigenicity of the tumour after gene transfer. These results suggest that the heat shock protein-65 gene could provide a novel approach for the treatment of established tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lukacs, K., Nakakes, A., Atkins, C. et al. In vivo gene therapy of malignant tumours with heat shock protein-65 gene. Gene Ther 4, 346–350 (1997). https://doi.org/10.1038/sj.gt.3300386
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300386
Keywords
This article is cited by
-
Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients
Cancer Gene Therapy (2009)
-
Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70
Cancer Gene Therapy (2005)
-
Induction of systemic antitumor immunity by gene transfer of mammalian heat shock protein 70.1 into tumors in situ
Cancer Gene Therapy (2001)
-
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
Nature Medicine (1998)
-
Immune responses to stress proteins: Applications to infectious disease and cancer
Biotherapy (1998)